1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Prosthetic-joint Infection: new trials by email Literature Review of Prosthetic-joint Infection trials Research Report on Prosthetic-joint Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty PLG0206, Placebo - Prosthetic-joint Infection | Phase 2 / Phase 3 | Recruiting | Peptilogics | 240 | 2026-02-03 | 2026-11-16 |
| A Second Trial of the Abbreviated Protocol Two-Stage Exchange VT-X7 Treatment System, Two-stage exchange arthroplasty, SOC Antibiotics - Prosthetic-joint Infection | Phase 2 | Completed | Osteal Therapeutics, Inc. | 76 | 2023-01-23 | 2025-01-07 |
Sodium Chloride (1)
Osteal Therapeutics, Inc. (1) · Peptilogics (1)
United States (2) · United Kingdom (1)